Business Description
Nu-Med Plus Inc
NAICS : 339112
SIC : 3841
ISIN : US67021R1041
Description
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | -11.31 | |||||
| Debt-to-Equity | -0.68 | |||||
| Debt-to-EBITDA | -0.83 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 69.7 | |||||
| 3-Year EPS without NRI Growth Rate | 63.2 | |||||
| 3-Year FCF Growth Rate | 50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.26 | |||||
| 9-Day RSI | 68.45 | |||||
| 14-Day RSI | 61.49 | |||||
| 6-1 Month Momentum % | 104.55 | |||||
| 12-1 Month Momentum % | 246.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.9 | |||||
| Shareholder Yield % | -1.16 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -307.88 | |||||
| ROIC % | -120 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -47.08 | |||||
| EV-to-EBITDA | -47.08 | |||||
| EV-to-FCF | -85.59 | |||||
| Earnings Yield (Greenblatt) % | -2.12 | |||||
| FCF Yield % | -1.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NUMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nu-Med Plus Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | 1.04 | ||
| Volatility % | 208.35 | ||
| 14-Day RSI | 61.49 | ||
| 14-Day ATR ($) | 0.008982 | ||
| 20-Day SMA ($) | 0.052881 | ||
| 12-1 Month Momentum % | 246.15 | ||
| 52-Week Range ($) | 0.009 - 0.09 | ||
| Shares Outstanding (Mil) | 83.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nu-Med Plus Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nu-Med Plus Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nu-Med Plus Inc Frequently Asked Questions
What is Nu-Med Plus Inc(NUMD)'s stock price today?
The current price of NUMD is $0.07. The 52 week high of NUMD is $0.09 and 52 week low is $0.01.
When is next earnings date of Nu-Med Plus Inc(NUMD)?
The next earnings date of Nu-Med Plus Inc(NUMD) is .
Does Nu-Med Plus Inc(NUMD) pay dividends? If so, how much?
Nu-Med Plus Inc(NUMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers